Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump
暂无分享,去创建一个
P. Kekenes-Huskey | X. Fang | Jordan R. Beach | S. Robia | Ellen E. Cho | Marsha P. Pribadi | J. Seflova | Sean R. Cleary | Jaroslava Seflova
[1] L. M. Espinoza-Fonseca,et al. Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells , 2022, The Journal of biological chemistry.
[2] G. Veglia,et al. A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca2+-ATPase , 2021, Structure.
[3] M. J. Lemieux,et al. Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA , 2021, eLife.
[4] G. Veglia,et al. A Kink in DWORF Helical Structure Controls the Activation of the Sarco-plasmic Reticulum Ca2+-ATPase , 2021, bioRxiv.
[5] Daniel R. Stroik,et al. The transmembrane peptide DWORF activates SERCA2a via dual mechanisms , 2021, The Journal of biological chemistry.
[6] M. Gautel,et al. When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein–protein interactions and protein stability , 2021, Human molecular genetics.
[7] J. Schmitt,et al. Molecular Noise-Filtering in the β-adrenergic Signaling Network by Phospholamban Pentamers , 2020, bioRxiv.
[8] L. M. Espinoza-Fonseca,et al. Atomistic Structure and Dynamics of the Ca2+-ATPase Bound to Phosphorylated Phospholamban , 2020, International journal of molecular sciences.
[9] E. Olson,et al. Gene Therapy with the DWORF Micropeptide Attenuates Cardiomyopathy in Mice. , 2020, Circulation research.
[10] Jeffrey J. Gray,et al. Protein docking and steered molecular dynamics suggest alternative phospholamban-binding sites on the SERCA calcium transporter , 2020, The Journal of Biological Chemistry.
[11] C. Charles,et al. Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia/reperfused isolated rat hearts , 2019, Peptides.
[12] Deo R. Singh,et al. Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers. , 2019, Journal of molecular biology.
[13] A. Zima,et al. Novel approach for quantification of endoplasmic reticulum Ca2+ transport. , 2019, American journal of physiology. Heart and circulatory physiology.
[14] Talley J. Lambert,et al. FPbase: a community-editable fluorescent protein database , 2019, Nature Methods.
[15] Bin Sun,et al. Thermodynamics of Cation Binding to the Sarcoendoplasmic Reticulum Calcium ATPase Pump and Impacts on Enzyme Function. , 2019, Journal of chemical theory and computation.
[16] E. Olson,et al. The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy , 2018, eLife.
[17] L. M. Espinoza-Fonseca,et al. Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca2+-ATPase at saturating Ca2+ conditions , 2018, The Journal of Biological Chemistry.
[18] A. Zima,et al. Redistribution of SERCA calcium pump conformers during intracellular calcium signaling , 2018, The Journal of Biological Chemistry.
[19] Peter M Kekenes-Huskey,et al. Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes. , 2017, Cell calcium.
[20] S. Robia,et al. Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer. , 2016, Biophysical journal.
[21] A. Zima,et al. R-CEPIA1er as a new tool to directly measure sarcoplasmic reticulum [Ca] in ventricular myocytes. , 2016, American journal of physiology. Heart and circulatory physiology.
[22] Akshay S. Desai,et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial , 2016, The Lancet.
[23] Stephen C. Cannon,et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle , 2016, Science.
[24] S. Harding,et al. The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective. , 2015, Human gene therapy.
[25] Tory M. Schaaf,et al. Discovery of Enzyme Modulators via High-Throughput Time-Resolved FRET in Living Cells , 2014, Journal of biomolecular screening.
[26] G. Veglia,et al. Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban , 2013, Proceedings of the National Academy of Sciences.
[27] P. Vangheluwe,et al. Distinct Roles of the C-terminal 11th Transmembrane Helix and Luminal Extension in the Partial Reactions Determining the High Ca2+ Affinity of Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2b (SERCA2b)* , 2012, The Journal of Biological Chemistry.
[28] David D. Thomas,et al. Nucleotide Activation of the Ca-ATPase* , 2012, The Journal of Biological Chemistry.
[29] Mark E. Anderson,et al. CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban. , 2012, Journal of molecular and cellular cardiology.
[30] David D. Thomas,et al. 2-Color Calcium Pump Reveals Closure of the Cytoplasmic Headpiece with Calcium Binding , 2012, PloS one.
[31] R. Hajjar,et al. Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome , 2012, Circulation research.
[32] A. Zima,et al. Phospholamban Binds with Differential Affinity to Calcium Pump Conformers* , 2011, The Journal of Biological Chemistry.
[33] David D. Thomas,et al. Oligomeric Interactions of Sarcolipin and the Ca-ATPase* , 2011, The Journal of Biological Chemistry.
[34] G. Veglia,et al. Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method , 2011, Proceedings of the National Academy of Sciences.
[35] L. Masterson,et al. Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A , 2011, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Bers,et al. Phosphomimetic Mutations Enhance Oligomerization of Phospholemman and Modulate Its Interaction with the Na/K-ATPase* , 2011, The Journal of Biological Chemistry.
[37] L. Jones,et al. Ca2+ Binding to Site I of the Cardiac Ca2+ Pump Is Sufficient to Dissociate Phospholamban* , 2009, The Journal of Biological Chemistry.
[38] Z. Hou,et al. Phosphomimetic Mutations Increase Phospholamban Oligomerization and Alter the Structure of Its Regulatory Complex* , 2008, Journal of Biological Chemistry.
[39] D. Bers,et al. Phospholamban Oligomerization, Quaternary Structure, and Sarco(endo)plasmic Reticulum Calcium ATPase Binding Measured by Fluorescence Resonance Energy Transfer in Living Cells* , 2008, Journal of Biological Chemistry.
[40] K. Campbell,et al. Förster Transfer Recovery Reveals That Phospholamban Exchanges Slowly From Pentamers but Rapidly From the SERCA Regulatory Complex , 2007, Circulation research.
[41] David D. Thomas,et al. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. , 2006, Journal of molecular biology.
[42] I. V. Negrashov,et al. Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer. , 2004, Biochemistry.
[43] A. Hovnanian,et al. Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 2 Isoforms and Characterization of Darier Disease (SERCA2) Mutants by Steady-state and Transient Kinetic Analyses* , 2003, Journal of Biological Chemistry.
[44] Y. Sugita,et al. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Ferrington,et al. Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. , 2002, Biochemistry.
[46] R. Cornea,et al. Close Proximity between Residue 30 of Phospholamban and Cysteine 318 of the Cardiac Ca2+ Pump Revealed by Intermolecular Thiol Cross-linking* , 2002, The Journal of Biological Chemistry.
[47] T. Vorherr,et al. NMR Solution Structure of Phospholamban , 2000 .
[48] D. Maclennan,et al. Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP* , 2000, The Journal of Biological Chemistry.
[49] W. Lew,et al. Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. , 1999, American journal of physiology. Heart and circulatory physiology.
[50] D. Maclennan,et al. Phospholamban Inhibitory Function Is Activated by Depolymerization* , 1997, The Journal of Biological Chemistry.
[51] D. D. Thomas,et al. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. , 1997, Biochemistry.
[52] J. East,et al. An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban. , 1996, The Biochemical journal.
[53] A. M. Mata,et al. The Modulation of Ca2+ Binding to Sarcoplasmic Reticulum ATPase by ATP Analogues Is pH-dependent (*) , 1995, The Journal of Biological Chemistry.
[54] H. Drexler,et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.
[55] Y. Sagara,et al. Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+. , 1993, The Journal of biological chemistry.
[56] G. Flik,et al. CHELATOR: an improved method for computing metal ion concentrations in physiological solutions. , 1992, BioTechniques.
[57] N. Alpert,et al. Altered Myocardial Force‐Frequency Relation in Human Heart Failure , 1992, Circulation.
[58] E. Carafoli,et al. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum , 1989, Nature.
[59] A. J. Brady,et al. Contractile force measured in unskinned isolated adult rat heart fibres , 1979, Nature.
[60] A. Katz,et al. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. , 1975, The Journal of biological chemistry.
[61] E. Kranias,et al. Phospholamban: a major determinant of the cardiac force-frequency relationship. , 2000, American journal of physiology. Heart and circulatory physiology.
[62] Godfrey L. Smith,et al. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. , 1999, Cardiovascular research.
[63] R. Bick,et al. Phosphorylation of a 100 000 dalton component and its relationship to calcium transport in sarcoplasmic reticulum from rabbit skeletal muscle. , 1980, Biochimica et biophysica acta.
[64] R. Albers. Biochemical aspects of active transport. , 1967, Annual review of biochemistry.
[65] H. P. Bowditch. Über die Eigenthümlichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen , 1871 .